保妇康栓联合辛复宁治疗宫颈高危型人乳头瘤病毒感染的疗效分析  

Analysis on the Effect of Baofukang Suppository combined with Xinfuning in the Treatment of Cervical High-risk Human Papillomavirus Infection

作　　者：戴星[1] 周静[1] 邹志雄 胡鸣[1] 

机构地区：[1]南昌大学第四附属医院妇产科,南昌330003

出　　处：《中国中医药现代远程教育》2015年第24期62-63,共2页Chinese Medicine Modern Distance Education of China

摘　　要：目的探讨宫颈高危型人乳头瘤病毒感染采用保妇康栓与辛复宁联用效果。方法选取宫颈高危型人乳头瘤病毒感染患者180例,均为我院2013年8月—2014年12月收治,随机分组,就辛复宁单用(对照组,n=90)与联用保妇康栓(观察组,n=90)效果展开对比。结果观察组宫颈高危型HPV感染经统计4个月、8个月的总有效率分别是为61.1%、87.8%,显著高于对照组4个月、8个月的总有效率,有显著统计学差异(P<0.05)。2组均无严重不良反应。结论针对宫颈高危型人乳头瘤病毒,采用保妇康栓与辛复宁联合治疗,可提高HPV转阴率,对改善患者预后有显著意义。Objective To investigate the combined effect of Xinfuning and Baofukang suppository in the treatment for cervical high-risk human papillomavirus（ hr-HPV） infection. Methods Selecting 180 cases with cervical hr-HPV infection in our hospital from August2013 to December 2014, they were randomly divided into Xinfuning observation group of 90 cases and combination control group of Baofukang and Xinfuning of 90 cases. The therapeutic effect was compared. Results The total effective rateof the combination group after4 months and 8 months was 61.1% and 87.8%, respectively, which was obviously higher than that of the control group after 4 months and8 months, respectively. There was significant difference between observation group and control group（ P〈0.05）. The two groups had no severe adverse reaction. Conclusion Xinfuning combined with Baofukang suppository in the treatment of high-risk human papillomavirus can increase negative conversion rate, and it is significant to improve the prognosis of the patients.

关 键 词：保妇康栓 辛复宁 宫颈高危型人乳头瘤病毒 中西医结合疗法 

分 类 号：R737.33[医药卫生—肿瘤]